Abstract
This study describes the prevalence of smoking among 3,220 pregnant women. Maternal and umbilical cord cotinine levels were compared with the women’s self-reported cigarette consumption, infant birth weight and antepartum and perinatal complications. Of the women who reported themselves as being active smokers (23%), 76% had a partner who smoked, and 38% reported exposure to environmental smoke in the workplace. Only 15% of nonsmokers had a partner who smoked, and 13% reported workplace exposure. The mean number of cigarettes/day was 20.5 (95% CI 19.6-21.4). The relative risk of having a small-for-gestational-age infant was significantly higher in smokers for mothers of both preterm (34-36 wks, RR= 3.38, 95% CI 1.25 - 9.16) and term babies (>- 37wks, RR= 2.04, 95% CI 1.58 - 2.63). Mean infant birth weight was 207 g lighter in the infants of smokers (p<0.001) and was inversely correlated to maternal serum cotinine level. Birth weight dropped by 0.99 g for every 1 ug/L increase in cotinine (r =-0.19, p<0.01).
Abrégé
Cette étude décrit la prévalence du tabagisme durant la grossesse, auprès de 3 220 Canadiennes. Les taux sanguins de cotinine de la mère et du cordon ombilical ont été comparés à la consommation de cigarettes déclarés par les participantes, au poids des nourrissons à la naissance et aux complications périnatales et postnatales. Parmi celles qui avouaient fumer activement (23 %), 76 % avaient un conjoint fumeur et 38 % étaient exposées à la fumée dans leur milieu de travail. Seulement 15 % des non fumeuses cohabitaient avec un fumeur, et 13 % rapportèrent être exposées à la fumée dans leur milieu de travail. La consommation moyenne s’élevait à 20,5 cigarettes/jour (95 % IC; 19,6 - 21,4). Le risque relatif de donner naissance à un bébé de petit poids prématuré (34-36 semaines; RR = 3,38; 95 % IC 1,25 - 9,16) ou à terme (>- 37 semaines; RR = 2,04; 95 % IC 1,58 - 2.63) était significative-ment plus élevé chez les fumeuses. Le poids moyen des nourrissons à la naissance issus de mères fumeuses était de 207 g inférieur à celui des nourrissons de mères non fumeuses (p<0,001), et était inversement proportionnel aux taux sanguins maternels de cotinine. En fait, le poids des nourrissons à la naissance diminuait de 0,99 g pour chaque augmentation de 1 μg/L de cotinine sanguin chez la mère (r = - 0,19; p<0,01).
Similar content being viewed by others
References
Feldman PR. Smoking and healthy pregnancy: Now is the time to quit. Md Med J 1985;34:982–86.
Meyer MB, Tonascia JA. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977;128:494–502.
Fielding JE. Smoking and pregnancy. N Engl J Med 1978; 298:337–39.
Mochizuki M, Maruo T, Masuko K, Ohtsu T. Effects of smoking on fetoplacental-maternal system during pregnancy. Am J Obstet Gynecol 1984;149:413–20.
Cliver SP, Goldenberg RL, Cutter GR, Hoffman HJ, Davis RO, Nelson KG. The effect of cigarette smoking on neonatal anthropometric measurements. Obstet Gynecol 1995;85:625–30.
Chelmow D, Andrew ED, Baker ER. Maternal cigarette smoking and placenta previa. Obstet Gynecol 1996;87:703–6.
Ernster VL. Women and smoking. Am J Public Health 1993;83:1202–3.
Camilli AE, McElroy LR, Reed KL. Smoking and pregnancy: A comparison of Mexican-American and non-Hispanic white women. Obstet Gynecol 1994;84:1033–37.
Williamson DF, Serdula MK, Kendrick JS, Binkin NJ. Comparing the prevalence of smoking in pregnant and nonpregnant women, 1985–1986. JAMA 1989;261:70–4.
Smoking behaviour of Canadians: A national alcohol and other drugs survey report 1989. Ottawa: Health and Welfare Canada, 1992.
Mittendorf R, Herschel M, Williams MA, Hibbard JU, Moawad AH, Lee K-S. Reducing the frequency of low birth weight in the United States. Obstet Gynecol 1994;83:1056–59.
Sexton M, Hebel JR. A clinical trial of change in maternal smoking and its effect on birth weight. JAMA 1984;251:911–15.
Kendrick JS, Zahniser SC, Miller N, et al. Integrating smoking cessation into routine public prenatal care: The Smoking Cessation in Pregnancy Project. Am J Public Health 1995;85:217–22.
Li CH, Windsor RA, Perkins L, Goldenberg RL, Lower JB. The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993;269:1519–24.
Peacock JL, Bland JM, Anderson HR, Brooke OG. Cigarette smoking and birthweight: Type of cigarette smoked and a possible threshold effect. Int J Epidemiol 1991;20:405.
Cnattingius S, Forman MR, Berendes HW, Graubard BI, Isotalo L. Effect of age, parity and smoking on pregnancy outcome: A population-based study. Am J Obstet Gynecol 1993;168:16–21.
Perez-Stable EJ, Marin G, Marin BV, Benowitz NL. Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis 1992;145:53–7.
Emmons KM, Abrams DB, Marshall R, et al. An evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposure. Prev Med 1994;23:35–9.
Ahijevych KL, Wewers ME. Patterns of cigarette consumption and cotinine levels among African American women smokers. Am J Respir Crit Care Med 1994; 150:1229–33.
Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: A review and meta-analysis. Am J Public Health 1994;84:1086–93.
Perez-Stable EJ, Benowitz NL, Marin G. Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med 1995:24;171–79.
Riboli E, Haley NJ, Tredaniel J, et al. Misclassification of smoking status among women in relation to exposure to environmental tobacco smoke. Eur Respir J 1995;8:285–90.
Perkins SL, Livesey JF, Escares E, Belcher J, Dudley DK. High-performance liquid-chromato-graphic method compared with a modified radioimmunoassay of cotinine in plasma. Clin Chem 1991;37:1989–93.
Arbuckle TE, Sherman GJ. An analysis of birth weight by gestational age in Canada. Can Med AssocJ 1989;140:157–65.
Benowitz NL, Kuyt F, Jacob P, Jones RT, Osman A-L. Cotinine disposition and effects. Clin Pharmacol Ther 1983;34:604–11.
Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985;8:384–95.
Donnenfeld AE, Pulkkinen A, Palomaki GE, Knight GJ, Haddow JE. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol 1993;168:781–2.
Haddow JE, Knight GJ, Palomaki GE, McCarthy JE. Second-trimester serum cotinine levels in nonsmokers in relation to birth weight. Am J Obstet Gynecol 1988;159:481–84.
Eskenazi B, Prehn AW, Christianson RE. Passive and active maternal smoking as measured by serum cotinine: The effect on birth weight. Am J Public Health 1995;85;395–8.
Bardy AH, Seppala T, Lillsunde P, et al. Objectively measured tobacco exposure during pregnancy: Neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol 1993;100:721–26.
Haddow JE, Knight GJ, Palomaki GE, Kloza EM, Wald NJ. Cigarette consumption and serum cotinine in relation to birth weight. Br J Obstet Gynaecol 1987;94:678–81.
Rebagliato M, Florey C du V, Bolumar F. Exposure to environmental tobacco smoke in nonsmoking pregnant women in relation to birth weight. Am J Epidemiol 1995;142:531–37.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perkins, S.L., Belcher, J.M. & Livesey, J.F. A Canadian Tertiary Care Centre Study of Maternal and Umbilical Cord Cotinine Levels as Markers of Smoking During Pregnancy: Relationship to Neonatal Effects. Can J Public Health 88, 232–237 (1997). https://doi.org/10.1007/BF03404788
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03404788